Skip to main content

Finance & Markets

Institutional Investors Are Buying Hyperliquid Strategies. Should You?

Key PointsInstitutional investors can buy stocks for many different reasons.

nasdaq.com ·1h ago

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Institutional Investors Are Buying Hyperliquid Strategies. Should You? fool.com

Read the original at nasdaq.com →

More in Finance & Markets

Insider Transaction: Cytokinetics CEO Robert Blum Sells 7,500 Shares for $575,700

Key PointsThe transaction involved the disposal of 7,500 shares.

1h ago ·nasdaq.com

Insider Transaction: Cytokinetics CEO Robert Blum Sells 7,500 Shares for $575,700

1h ago ·finance.yahoo.com

This Under-the-Radar Healthcare Stock Yields Nearly 8.5%. Here's Whether That Income Is Too Good to Be True.

Key PointsPerrigo is a healthcare company with a huge 8.3% dividend yield.

2h ago ·nasdaq.com

Up 20% in 1 Day, is Hyperliquid Worth Buying Hand Over Fist Right Now?

The decentralized crypto exchange appears to have an ally in the White House.

1h ago ·fool.com

SA Asks: What are the most promising oncology companies right now?

1h ago ·seekingalpha.com

Apple Announced Its Largest-Ever Stock Buyback Under Tim Cook's Leadership. Here's Why the Size of the Repurchase Program Matters for Shareholders.

No company has bought back more of its shares than Apple over the last decade.

1h ago ·fool.com

More from Saturday 22 August →